c-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients [Corrigendum]
Lin SH, Wang HK, Yeh KT, et al. Cancer Manag Res. 2019;11:5163–5169.Following a review of the paper post-publication, the authors found two errors.The authors advised that firstly, they incorrectly listed the CCH IRB number on page 5164. Therefore, the sentence &ldquo...
Main Authors: | Lin SH, Wang HK, Yeh KT, Tai HC, Wang HY, Huang LR, Chiu CW, Chung CM, Velmurugan BK |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-08-01
|
Series: | Cancer Management and Research |
Online Access: | https://www.dovepress.com/httpssitesgooglecomsitecorrigendum-dmpiheguiderevisedaugus-peer-reviewed-article-CMAR |
Similar Items
-
c-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients
by: Lin SH, et al.
Published: (2019-06-01) -
miR-105 Promotes the Progression and Predicts the Prognosis for Oral Squamous Cell Carcinoma (OSCC)
by: Zhang HY, et al.
Published: (2020-11-01) -
CIP2A overexpression in Taiwanese oral cancer patients
by: Velmurugan BK, et al.
Published: (2019-04-01) -
Exploring The Role of LGR5 in Oral Squamous Cell Carcinoma (OSCC)
by: Wei Chia Chen, et al.
Published: (2013) -
Prognostic Significance of Lymph Node Pattern in Oral Squamous Cell Carcinoma (OSCC)
by: Makesh Raj L.S., et al.
Published: (2014-01-01)